Healthcare Hedge Fund Just Invested $24.5M in Immunovant
A healthcare hedge fund just disclosed a sizable stake in Immunovant, signaling confidence in the biotech company’s l...
Benchmarks provide objective yardsticks to assess results, set expectations, and keep portfolios aligned with objectives.
20,321 articlesA healthcare hedge fund just disclosed a sizable stake in Immunovant, signaling confidence in the biotech company’s l...
Elon Musk publicly backs Warren Buffett’s long-running deficit-cap idea, positioning the plan as a potential pivot in...
Oracle is sitting on a massive backlog that could redefine its AI trajectory in 2026. This deep dive breaks down what...
Strategy widens its ATM funding to over $60B to buy BTC, signaling bigger bets on the digital asset. The move could l...
This in-depth analysis explores what could drive ASML stock in 2026, with practical scenarios, risk factors, and clea...
Morgan Stanley and Charles Schwab are integrating direct crypto trading into ordinary brokerage accounts, aiming to c...
In markets that tempt action, sometimes the strongest move is restraint. This article lays out why the argument doing...
Investing in niche space stocks can be volatile. This analysis breaks down why gilat satellite networks stock dropped...
Pershing Square’s bill ackman been quietly building a Microsoft stake since February signals a patient, long-term bet...
Looking for reliable, income-generating investments you can hold for decades? This guide picks three dividend stocks ...
Parsons Corp faces a tough mix: a record backlog rising margins boost profitability, yet an upcoming policy and contr...
As SpaceX moves toward a historic public listing, Antonio Gracias could see his private stake surge into the tens of ...